Target Price | $7.43 |
Price | $2.84 |
Potential |
161.44%
register free of charge
|
Number of Estimates | 2 |
2 Analysts have issued a price target Vivos Therapeutics Inc 2025 .
The average Vivos Therapeutics Inc target price is $7.43.
This is
161.44%
register free of charge
$8.25
190.49%
register free of charge
$6.60
132.39%
register free of charge
|
|
A rating was issued by 2 analysts: 2 Analysts recommend Vivos Therapeutics Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Vivos Therapeutics Inc stock has an average upside potential 2025 of
161.44%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 13.80 | 16.25 |
13.86% | 17.72% | |
Net Margin | -274.46% | -418.57% |
50.07% | 52.50% |
2 Analysts have issued a sales forecast Vivos Therapeutics Inc 2024 . The average Vivos Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
The average Vivos Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
2023 | $-37.9m | 56.99% |
---|---|---|
2024 |
$-68.0m
79.53%
Unlock
|
2023 | -274.46% | 50.07% |
---|---|---|
2024 |
-418.57%
52.50%
Unlock
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -11.14 | -20.00 |
56.99% | 79.53% | |
P/E | negative | |
EV/Sales | 0.52 |
The average Vivos Therapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
2023 | $-11.14 | 56.99% |
---|---|---|
2024 |
$-20.00
79.53%
Unlock
|
Current | -0.45 | 221.43% |
---|---|---|
2024 |
-0.14
68.89%
Unlock
|
Based on analysts' sales estimates for 2024, the Vivos Therapeutics Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Vivos Therapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.